Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice
- PMID: 16006012
- DOI: 10.1016/j.neurobiolaging.2005.04.010
Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice
Abstract
In addition to genetic factors, environmental factors have long been suspected to contribute to the pathogenesis of Parkinson's disease (PD). We investigated the possible interaction between genetic factors and neurotoxins by testing whether alpha-synuclein A30P Tg5093 transgenic mice show increased sensitivity to secondary toxic insults like 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or rotenone. While sensitivity to chronic treatment with rotenone was not enhanced in the Tg5093 line, chronic treatment with 80 or 150 mg/kg MPTP resulted in increased deterioration of the nigrostriatal dopaminergic system as assessed by quantitation of nigral tyrosine hydroxylase (TH) positive neurons and striatal dopamine (DA) levels in Tg5093 mice when compared to non-transgenic littermate controls. Thus, the results of this study demonstrate a role for the overexpression of mutant human alpha-synuclein A30P in increased vulnerability of DA neurons to MPTP.
Similar articles
-
Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.J Neurobiol. 2002 Oct;53(1):1-10. doi: 10.1002/neu.10094. J Neurobiol. 2002. PMID: 12360578
-
Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.Neurotoxicology. 2004 Sep;25(5):761-9. doi: 10.1016/j.neuro.2004.05.002. Neurotoxicology. 2004. PMID: 15288507
-
Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.Neurosci Lett. 2008 Dec 26;448(2):184-8. doi: 10.1016/j.neulet.2008.10.070. Epub 2008 Oct 25. Neurosci Lett. 2008. PMID: 18977411
-
alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.CNS Neurol Disord Drug Targets. 2010 Aug;9(4):482-90. doi: 10.2174/187152710791556177. CNS Neurol Disord Drug Targets. 2010. PMID: 20522009 Review.
-
Animal models of neurological disease.Adv Exp Med Biol. 2010;671:23-40. doi: 10.1007/978-1-4419-5819-8_3. Adv Exp Med Biol. 2010. PMID: 20455493 Review.
Cited by
-
Synergistic stress exacerbation in hippocampal neurons: Evidence favoring the dual-hit hypothesis of neurodegeneration.Hippocampus. 2016 Aug;26(8):980-94. doi: 10.1002/hipo.22580. Epub 2016 Mar 29. Hippocampus. 2016. PMID: 26934478 Free PMC article.
-
Animal models of Parkinson's disease: vertebrate genetics.Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a009324. doi: 10.1101/cshperspect.a009324. Cold Spring Harb Perspect Med. 2012. PMID: 22960626 Free PMC article. Review.
-
Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Exerts Neurotoxicity in Models of Parkinson's Disease.Mol Neurobiol. 2017 Nov;54(9):6970-6983. doi: 10.1007/s12035-016-0199-2. Epub 2016 Oct 26. Mol Neurobiol. 2017. PMID: 27785754
-
Modulation of alpha-synuclein expression in transgenic animals for modelling synucleinopathies--is the juice worth the squeeze?Neurotox Res. 2008 Dec;14(4):329-41. doi: 10.1007/BF03033857. Neurotox Res. 2008. PMID: 19073436 Free PMC article. Review.
-
Parkinson's disease.Subcell Biochem. 2012;65:389-455. doi: 10.1007/978-94-007-5416-4_16. Subcell Biochem. 2012. PMID: 23225012 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
